Acute Blindness in dogs (Amaurosis)
- Synonyms: Amaurosis
- Occurrence: rarer
- Location of disease: Head/Neck
When to visit the vet?
Urgent see a veterinarian within 24 hours
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
The term “amaurosis” refers to complete blindness without detectable morphological changes in the eye. In veterinary practice, the term is often used synonymously with functional blindness, regardless of whether the cause lies in the eye itself (ocular), along the optic nerve (N. opticus), or in the central visual system. Blindness may be unilateral or bilateral, acute or chronic, reversible or irreversible. It represents a significant limitation for the affected animal, but is often compensated for surprisingly well by the dog.
The most important facts at a glance
Amaurosis is the medical term for blindness and can have a wide variety of causes—from primary eye diseases to central nervous system disorders. Diagnosis is complex and requires both ophthalmological and neurological expertise. While some forms are reversible, the majority of hereditary or degenerative causes are incurable. Early detection and adaptation of the living environment contribute significantly to the quality of life for blind dogs.
Causes
Blindness in dogs can be due to various causes, including genetic factors, age-related degeneration, injuries, or diseases that directly affect the eyes. Blindness can occur suddenly or gradually and may affect one or both eyes.
The causes of Amaurosis are diverse and can be located along the entire visual pathway. A distinction is made between:
- Retinal causes: progressive retinal atrophy (PRA), retinal dysplasia, retinal detachment, retinal degeneration due to toxins or deficiencies (e.g., vitamin A), light toxicity
- Optic nerve causes: Inflammation (optic neuritis), traumas, tumors, ischemic damage
- Central causes: Lesions in the visual cortex (occipital lobe), Sehstörungen due to epilepsy, meningoencephalitis
- Toxic/metabolic: e.g., due to ethylene glycol, strychnine, hypoglycemia, hepatic encephalopathy
- Infectious causes: e.g., Canine Distemper Virus (CDV), toxoplasmosis, neosporosis
Hereditary factors also play a role, especially in PRA, which is inherited in an autosomal-recessive manner in certain breeds (e.g., Retriever, Collie, Poodle).
Symptoms
Blindness often manifests as a sudden or gradual onset of an unsteady gait, bumping into objects, anxiety in unfamiliar environments, and problems climbing stairs or jumping. The menace reflex (blinking in response to a threatening movement) is usually absent on both sides, as is the fixation reaction. Pupillary light reflexes (PLR) may be preserved, especially in cases of retinal or central blindness. Some dogs show additional Behavioral changes, Vocalizations, or Restlessness. Depending on the cause, ocular changes (e.g., gray retina, optic nerve atrophy) may be visible or completely absent.
The pattern of “painless visual impairment to blindness + dilated or sluggish pupillary response to light + absent threat reflex” is particularly indicative of blindness. The pupillary light reflex helps with classification (peripheral, eye vs. central, brain).
Therapy
Treatment depends on the underlying cause:
- Inflammatory causes: e.g., in optic neuritis: high-dose glucocorticoids, possibly immunomodulatory therapy
- Infections: specific antibiotics (e.g., clindamycin for toxoplasmosis), antiviral therapies are limited
- Poisoning or metabolic causes: rapid detoxification, supportive therapy (e.g., infusions, glucose)
- Retinal causes such as PRA are usually not treatable, as they are degenerative processes
- Central blindness caused by masses or inflammation can be addressed surgically or with medication, though the prognosis is often limited
Visual rehabilitation through adaptation to the new living situation is central: orientation aids, protective goggles, sound-assisted communication.
Prognosis and follow-up care
The prognosis depends on the cause. In the case of reversible, inflammatory, or metabolic causes, visual function can be partially restored. In degenerative diseases such as PRA or retinal dysplasia, the blindness is irreversible. Dogs often compensate well for blindness through their other senses (hearing and smell), especially when the progression is gradual. Regular follow-up appointments for monitoring progress, infection surveillance, and, if necessary, neurological status checks are advisable. Adapting the home environment (avoiding tripping hazards) is important for quality of life.
Prevention
Prevention of blindness depends on the underlying cause. Regular eye examinations, especially in breeds with a genetic predisposition, are crucial. Eye injuries must be treated by a veterinarian immediately. Chronic diseases such as diabetes or high blood pressure should be consistently controlled to prevent secondary damage to the retina. Vaccination against distemper and other infections protects against viral eye damage. A balanced diet with an adequate intake of antioxidants supports eye health. Owners should watch early for Symptoms: such as increased blinking, cloudiness, or changes in orientation behavior, so they can take action in time.
Outlook on current research
Research focuses include the genetic identification of hereditary retinal degenerations (e.g., PRA genes), gene-therapy approaches to retinal regeneration, and stem cell therapies. Experimental therapy uses viral vectors for gene correction, as has already been shown successfully in humans (e.g., AAV vectors). Neuroprotective strategies and retinal implants are also the subject of translational studies, but their applicability to dogs is still under development.
Frequently Asked Questions (FAQs)
1. Can a blind dog live a normal life?
2. Is sudden Blindness an emergency?
3. What can be done for hereditary Blindness?
4. Can a dog go blind due to stress or trauma?
Literature
- Meekins, J. M. (2015). Acute blindness. Topics in Companion Animal Medicine, 30(3), 118–125. https://doi.org/10.1053/j.tcam.2015.07.005
- Montgomery, K. W., van der Woerdt, A., & Cottrill, N. B. (2008). Acute blindness in dogs: Sudden acquired retinal degeneration syndrome versus neurological disease (140 cases, 2000–2006). Veterinary Ophthalmology, 11(5), 314–320. https://doi.org/10.1111/j.1463-5224.2008.00652.x
- Komáromy, A. M., Abrams, K. L., Heckenlively, J. R., Lundy, S. K., Maggs, D. J., Leeth, C. M., MohanKumar, P. S., Petersen-Jones, S. M., & Serreze, D. V. (2016). Sudden acquired retinal degeneration syndrome (SARDS)—A review and proposed strategies toward a better understanding of pathogenesis, early diagnosis, and therapy. Veterinary Ophthalmology, 19(4), 319–331. https://doi.org/10.1111/vop.12291
- Heller, A. R., van der Woerdt, A., Gaarder, J. E., Sapienza, J. S., Hernandez-Merino, E., Abrams, K., Church, M. L., & La Croix, N. (2017). Sudden acquired retinal degeneration in dogs: Breed distribution of 495 canines. Veterinary Ophthalmology, 20(2), 103–106. https://doi.org/10.1111/vop.12370
- Leis, M. L., Lucyshyn, D. R., Bauer, B. S., Grahn, B. H., & Sandmeyer, L. S. (2017). Sudden acquired retinal degeneration syndrome in western Canada: 93 cases. The Canadian Veterinary Journal, 58(11), 1195–1199.
- Auten, C. R., Thomasy, S. M., Kass, P. H., Good, K. L., Hollingsworth, S. R., & Maggs, D. J. (2018). Cofactors associated with sudden acquired retinal degeneration syndrome: 151 dogs within a reference population. Veterinary Ophthalmology, 21(3), 264–272. https://doi.org/10.1111/vop.12504
- Oh, A., Foster, M. L., Williams, J. G., Zheng, C., Ru, H., Lunn, K. F., & Mowat, F. M. (2019). Diagnostic utility of clinical and laboratory test parameters for differentiating between sudden acquired retinal degeneration syndrome and pituitary-dependent hyperadrenocorticism in dogs. Veterinary Ophthalmology, 22(6), 842–858. https://doi.org/10.1111/vop.12661
- Washington, D. R., Li, Z., Fox, L. C., & Mowat, F. M. (2021). Canine sudden acquired retinal degeneration syndrome: Owner perceptions on the time to vision loss, treatment outcomes, and prognosis for life. Veterinary Ophthalmology, 24(2), 156–168. https://doi.org/10.1111/vop.12855
- McCarthy, P. M. G., Whittaker, C. J. G., Annear, M. J., Hall, E., Hamzianpour, N., Irving, W., Reynolds, B., Smith, J. R., Thomasy, S. M., & Caruso, K. A. (2024). Parasiticide use and obesity in dogs with sudden acquired retinal degeneration syndrome. Journal of the American Veterinary Medical Association, 262(12), 1–6. https://doi.org/10.2460/javma.24.02.0140
- Heyward, J. L., Dubielzig, R. R., Ray, C., Teixeira, L. B. C., & Mowat, F. M. (2026). Histopathologic and ultrastructural features of the choriocapillaris in dogs with sudden acquired retinal degeneration syndrome and progressive retinal atrophy. Veterinary Pathology, 63(2), 265–274. https://doi.org/10.1177/03009858251367410